Dianthus Therapeutics | MGTA - SCHULD

Aktienkurs
86.92
Täglich Wechseln
7.69 9.71%
Monatlich
74.12%
Jährlich
271.77%
Q1 Prognose
63.23




SCHULD Veränderung Datum
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Avita Medical AUD 46.05M 1.46M 2025-12
Celltrion KRW 171.09B 2.05T 2025-06
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
IQVIA Holdings USD 15.72B 767M 2025-12
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 106.24M 1.5M 2025-09
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Moderna USD 734M 7M 2025-09
Neuren Pharmaceuticals AUD 0 0 2024-12
Organon & Co USD 8.83B 68M 2025-09
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 49.42M 1.98M 2025-12
Qiagen NV USD 2.13B 683.16M 2025-09
Revvity USD 3.37B 5.86M 2025-09
Sartorius EUR 4.66B 25.7M 2025-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tectonic Therapeutic USD 876K 115K 2024-12
Tilray USD 640.95M 35.17M 2022-06
Viatris USD 14.41B 25.6M 2025-12
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Zz Pientze Pharmaceu CNY 1.07B 52.69M 2025-06